Preliminary studies point out conolidine could inhibit particular ion channels, minimizing neuronal excitability and restricting discomfort signals. This mechanism is particularly appropriate in neuropathic suffering, where irregular signaling leads to persistent pain. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort perception. ... https://richardl047fyn7.blogsvila.com/profile